TP53 and central nervous system cancer: Furthermore, p53 has been shown to inhibit glioma growth by inducing ferroptosis [84], while a novel histone deacetylase inhibitor called MPT0B291 has demonstrated efficacy in suppressing glioma growth both in vitro and in vivo by increasing the level of p53 acetylation [62].